About
Diagnostic imaging and therapeutic agents for neurodegenerative diseases
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
2
As Collaborator
3
Total Enrollment
14,726
By Phase
PHASE1: 2PHASE2: 1
By Status
COMPLETED: 4UNKNOWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT04464681Collaborator
Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects
PHASE1Completed
18 participants
Started: Mar 30, 2020 · Completed: Nov 30, 2020
NCT04609059Collaborator
First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation
PHASE2Unknown
42 participants
Started: May 7, 2019 · Completed: Dec 31, 2020
NCT03643601Lead Sponsor
A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease
N/ACompleted
14,415 participants
Started: Sep 24, 2018 · Completed: Dec 4, 2018
NCT03328364Lead Sponsor
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
N/ACompleted
211 participants
Started: Dec 1, 2017 · Completed: Dec 24, 2017
NCT03055403Collaborator
First-in-Human Dose Escalation Study of M201-A in Healthy Japanese Subjects
PHASE1Completed
40 participants
Started: Feb 17, 2017 · Completed: Nov 28, 2017
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...